Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201304002 Principal Investigator: Ma, Cynthia
Title: A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Clinical Study of Intravenously Administered MM-302 Monotherapy and in Combination with Trastuzumab with or without Cyclophosphamide in Patients with Advanced HER2 Positive Breast Cancer
Phase: I Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to evaluate MM-302 in subjects with advanced HER2+ breast cancer.
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)